Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Ata de Congresso
|
![]() |
PharmacologyAAPRO, MattiEuropean journal of cancer. Supplement (1990), 2001, Vol.37 (7), p.S251-S252 [Periódico revisado por pares]Oxford: ElsevierTexto completo disponível |
2 |
Material Type: Ata de Congresso
|
![]() |
Three years' follow-up from the ATAC trial is sufficient to change clinical practice: a debate. DiscussionAAPRO, Matti S ; FORBES, John F ; HENDERSON ; HORTOBAGYI ; KLIJN ; MARANG ; BELLBreast cancer research and treatment, 2003, Vol.80, p.S3-S18 [Periódico revisado por pares]Dordrecht: SpringerTexto completo disponível |
3 |
Material Type: Ata de Congresso
|
![]() |
Cancer treatment with pirarubicin-a new anthracycline agent, Hamburg, August 19, 1990ABE, Osahiko ; DRINGS, PeterAmerican journal of clinical oncology, 1990, Vol.13 [Periódico revisado por pares]Hagerstown, MD: Lippincott Williams & WilkinsTexto completo disponível |
4 |
Material Type: Ata de Congresso
|
![]() |
Vaccinia virus MUC1 immunization of mice : immune response and protection against the growth of murine tumors bearing the MUC1 antigenACRES, R. B ; HAREUVENI, M ; BALLOUL, J.-M ; KIENY, M.-PJournal of immunotherapy, 1993, Vol.14 (2), p.136-143New York, NY: Raven PressSem texto completo |
5 |
Material Type: Ata de Congresso
|
![]() |
Tumour necrosis and prognosis in Ewing's sarcomaAERMAN, MActa orthopaedica Scandinavica. Supplementum, 1997, Vol.68 (273), p.130-132Basingstoke: Taylor & FrancisTexto completo disponível |
6 |
Material Type: Ata de Congresso
|
![]() |
Interferon-alpha therapy in malignant diseases, Athens, 1-4 November, 1990AGUET, Michel ; MARTIN-ODEGARD, Brit ; GILES, Francis J ; TALPAZ, MosheBritish journal of haematology, 1991, Vol.79 [Periódico revisado por pares]Oxford: BlackwellSem texto completo |
7 |
Material Type: Ata de Congresso
|
![]() |
Turmor cell vaccination and IL-2 therapyAHLERT, THybridoma, 1993, Vol.12 (5), p.549-552Larchmont, NY: LiebertTexto completo disponível |
8 |
Material Type: Ata de Congresso
|
![]() |
Cytogenetic and breakpoint cluster region (bcr) changes in chronic myelogenous leukaemia treated with low-dose alpha interferonAITCHISON, R ; MCSWEENEY, E ; BUTLER, L ; WEIDEMANN, L ; NEWLAND, A. CEuropean journal of cancer (1990), 1991, Vol.27 [Periódico revisado por pares]Oxford: ElsevierSem texto completo |
9 |
Material Type: Ata de Congresso
|
![]() |
Treatment of patients with upper gastrointestinal carcinomasAJANI, J. ASeminars in oncology, 1997, Vol.24 (6), p.S19.72-S19.76 [Periódico revisado por pares]Philadelphia, PA: ElsevierSem texto completo |
10 |
Material Type: Ata de Congresso
|
![]() |
Weekly paclitaxel in patients with advanced lung cancer: Preliminary data from a phase II trialAKERLEY, W ; CHOY, H ; SAFRAN, H ; SIKOV, W ; REGE, V ; SAMBANDAM, S ; WITTELS, ESeminars in oncology, 1997, Vol.24 (4), p.S12.10-S12.13 [Periódico revisado por pares]Philadelphia, PA: ElsevierSem texto completo |